Catalent to provide fill-finish for Moderna's COVID-19 vaccine

By The Science Advisory Board staff writers

June 25, 2020 -- Catalent will collaborate with Moderna for large-scale commercial fill-finish manufacturing of Moderna's messenger RNA (mRNA)-based COVID-19 vaccine candidate, mRNA-1273, at Catalent's biologics facility in Bloomington, IN.

Under the agreement, Catalent will provide vial filling and packaging capacity, as well as additional staffing required for around-the-clock manufacturing operations to support the production of an initial 100 million doses of the vaccine candidate. The Bloomington biologics facility will provide vial filling using barrier isolator technology within the 875,000-sq-ft space. Production of these doses are intended to supply the U.S. market starting in the third quarter of 2020.

Catalent will also provide clinical supply services from its facilities in Philadelphia, PA. This includes packaging and labeling, storage, and distribution services to support Moderna's phase III clinical trial.

Copyright © 2020
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here